Rua Life Sciences PLC
LSE:RUA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ausnutria Dairy Corp Ltd
OTC:AUDYF
|
CN |
|
Inbound Tech Inc
TSE:7031
|
JP |
|
PTC India Financial Services Ltd
NSE:PFS
|
IN |
|
Titan Machinery Inc
NASDAQ:TITN
|
US |
|
Solvac SA
XBRU:SOLV
|
BE |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| UK |
|
Rua Life Sciences PLC
LSE:RUA
|
8.4m GBP |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.5T JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
55.2B USD |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
94.8B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.8B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.9B CNY |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
870.8B JPY |
Loading...
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
35.2B CNY |
Loading...
|
Market Distribution
| Min | -1 510% |
| 30th Percentile | 0.4% |
| Median | 0.5% |
| 70th Percentile | 0.7% |
| Max | 7 323.1% |
Other Profitability Ratios
Rua Life Sciences PLC
Glance View
RUA Life Sciences Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. The company is headquartered in Ayrshire, Ayrshire and currently employs 32 full-time employees. The firm is a manufacturer of medical devices and licensor of its IP and know-how together with developing medical devices utilizing its polymer IP. The firm operates through four businesses. Its RUA Medical business provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class seven and eight cleanroom suites. Its RUA Biomaterials is the depository of the IP and licensing rights to a range of biostable, implantable polymers, including Elast-EonTM and ECSilTM. Its RUA Vascular business is the legal manufacturer and IP holder of the Company’s cardiovascular and soft tissue patches and bore vascular grafts. Its RUA Structural Heart business holds the intellectual property relating to the Company’s synthetic heart valve technology.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Rua Life Sciences PLC is 77.1%, which is below its 3-year median of 81.1%.
Over the last 3 years, Rua Life Sciences PLC’s Gross Margin has decreased from 83.4% to 77.1%. During this period, it reached a low of 77.1% on Apr 3, 2025 and a high of 84.4% on Sep 30, 2022.
